ClinicalTrials.gg
Enrolling by invitationNCT07941219Updated Nov 17, 2026

Effects of a Powered Hip Exoskeleton on Dual-Task Performance in Older Adults Following Adaptation Under Physical and Mental Fatigue

An interventional study of with and without wearing the power hip exoskeleton and adaptation training in Fatigue Condition and Adaptation, sponsored by National Cheng-Kung University Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Basic science

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 87 studies in Fatigue with a site in Taiwan — 16 open to participants now, 19 under way, 3 of them phase 3. Fatigue · Taiwan.

Planned enrollment
47th of 71
40 · median 60
Started
2026
with 5 others
No phase
59 of 87
9 open now
Primary completion
2029-07
later than 17 of 18 live
Registered
87th of 87
by date

Among the 87 studies in Fatigue with a site in Taiwan, this one is the 47th largest by planned enrollment of the 71 interventional ones that give a count, is one of 6 that started in 2026, is one of 59 with no phase, reaches primary completion later than 17 of the 18 other live ones, and was the 87th registered.

Fatigue

2,233 studies on the registry are indexed under Fatigue; 429 are open to participants now.

Browse Fatigue studies →

Open to participants now

16 of the 87 studies in Fatigue with a site in Taiwan are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 240 Fatigue studies recruiting now, 112 (47%) set no upper age limit and 98 (41%) stop at 75 or younger; 23 take children under 18; 73 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 87 studies in Fatigue with a site in Taiwan, or all of them as a file.
02

Study summary

This study includes three sections: The first section aims to investigate whether adaptation to using a powered hip exoskeleton can improve dual-task performance and alter prefrontal cortical modulation in older adults. The second and third sections aim to investigate whether a hip exoskeleton device can improve dual task performance and alter prefrontal cortical modulation for older adults during either muscle fatigue or mental fatigue conditions.

03

Conditions studied

  • Fatigue Condition
  • Adaptation

Browse trials for

Keywords

  • adaptation
  • fatigue
  • older adult
  • dual task
  • exoskeleton
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy older adults who are over 65 years old
  • able to ambulate continuously for one hour without an assistive device
  • no cognitive issue (>24)
  • being able to hear and follow the given instructions through the headset
  • No neurological or degenerative disease that influences walking performance.

Exclusion criteria

Exclusion Criteria:

  • \< 24
  • neurological of degenerative diseases that influence walking performance
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    single arm _pre and post

    Device: with and without wearing the power hip exoskeleton · Behavioral: adaptation training

Interventions

  • Devicewith and without wearing the power hip exoskeleton

    Under mental and muscle fatigue condition, to see how power hip exoskeleton device alter dual task walking performance and cortical load.

  • Behavioraladaptation training

    Instruct patients to walk with the power hip exoskeleton device for four adaptation sessions (6 minutes for each)

06

What researchers measure

Primary outcomes

  1. walking speed

    meausred during the 40-meter oval walkway

    Time frame: single experimental session (Day 1)

  2. stride time

    calculated over the 40-meter oval walkway

    Time frame: single experimental session (Day 1)

  3. Stride length

    calculated during 40-meter walkway

    Time frame: single experimental session (Day 1)

  4. Functional Near Infrared spectroscopy (fNIRs)

    reflect local cortical activation level alteration

    Time frame: single experimental session (Day 1)

Secondary outcomes

  1. correct response rate

    correct response rate of concurrent cognitive test

    Time frame: single experimental session (Day 1)

  2. reaction time

    time require to response to the cognitive question

    Time frame: single experimental session (Day 1)

07

Study locations

1 site
  • Department Physical therapy National Cheng Kung University
    Tainan, 704, Taiwan
08

References and documents

Publications

  • Abram SJ, Poggensee KL, Sanchez N, Simha SN, Finley JM, Collins SH, Donelan JM. General variability leads to specific adaptation toward optimal movement policies. Curr Biol. 2022 May 23;32(10):2222-2232.e5. doi: 10.1016/j.cub.2022.04.015. Epub 2022 May 9. PubMed 35537453 ↗
  • Gordon KE, Ferris DP. Learning to walk with a robotic ankle exoskeleton. J Biomech. 2007;40(12):2636-44. doi: 10.1016/j.jbiomech.2006.12.006. Epub 2007 Feb 2. PubMed 17275829 ↗
  • Galle S, Malcolm P, Derave W, De Clercq D. Adaptation to walking with an exoskeleton that assists ankle extension. Gait Posture. 2013 Jul;38(3):495-9. doi: 10.1016/j.gaitpost.2013.01.029. Epub 2013 Mar 5. PubMed 23465319 ↗
  • De Bock S, Rossini M, Lefeber D, Rodriguez-Guerrero C, Geeroms J, Meeusen R, De Pauw K. An Occupational Shoulder Exoskeleton Reduces Muscle Activity and Fatigue During Overhead Work. IEEE Trans Biomed Eng. 2022 Oct;69(10):3008-3020. doi: 10.1109/TBME.2022.3159094. Epub 2022 Sep 19. PubMed 35290183 ↗
  • Clark DJ. Automaticity of walking: functional significance, mechanisms, measurement and rehabilitation strategies. Front Hum Neurosci. 2015 May 5;9:246. doi: 10.3389/fnhum.2015.00246. eCollection 2015. PubMed 25999838 ↗
  • Behrens M, Mau-Moeller A, Lischke A, Katlun F, Gube M, Zschorlich V, Skripitz R, Weippert M. Mental Fatigue Increases Gait Variability During Dual-task Walking in Old Adults. J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):792-797. doi: 10.1093/gerona/glx210. PubMed 29077783 ↗
  • Bastian AJ. Understanding sensorimotor adaptation and learning for rehabilitation. Curr Opin Neurol. 2008 Dec;21(6):628-33. doi: 10.1097/WCO.0b013e328315a293. PubMed 18989103 ↗
  • Barbieri FA, Santos PC, Lirani-Silva E, Vitorio R, Gobbi LT, van Dieen JH. Systematic review of the effects of fatigue on spatiotemporal gait parameters. J Back Musculoskelet Rehabil. 2013;26(2):125-31. doi: 10.3233/BMR-130371. PubMed 23640313 ↗
  • Baek CY, Yoon HS, Kim HD, Kang KY. The effect of the degree of dual-task interference on gait, dual-task cost, cognitive ability, balance, and fall efficacy in people with stroke: A cross-sectional study. Medicine (Baltimore). 2021 Jun 18;100(24):e26275. doi: 10.1097/MD.0000000000026275. PubMed 34128859 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Jul 2029, 33 months after the start.

Of 936 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 33 months is above that.

Counting every sponsor, half of 989 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartActual
Oct 22, 2026
Primary completionEst.
Jul 31, 2029
CompletionEst.
Jul 31, 2029
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941219
Collaborators
Tainan Hospital,Taiwan
Responsible party
Yi-Ying Tsai (Assistant Professor, National Cheng-Kung University Hospital) — Principal investigator
First posted
Nov 17, 2026
Start date
Oct 22, 2026
Primary completion
Jul 31, 2029 (estimated)
Completion
Jul 31, 2029 (estimated)
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion